US 7786285
Recombinant vaccine against botulinum neurotoxin
granted A61KA61K39/00A61K39/08
Quick answer
US patent 7786285 (Recombinant vaccine against botulinum neurotoxin) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K39/00, A61K39/08